Health Canada has recently reported the loss of 23 young women in the last few months in our country.  Synchronically, these 23 victims were all taking the two most commonly prescribed contraceptives pills at the time of their death. According to Health Canada and the Canadian Vigilance Program, these sudden deaths are not fortuitous nor coincidental.

In fact, medical consultants discovered that Yaz and Yasmin is also the cause of 600 other adverse reactions reported among other regular users since 2007. These symptoms include unexplained fainting, pulmonary issues and occasional blood clots. Beyond these concerns, twenty-three women under the age of twenty-six loss their life including a young adolescent of fourteen years old.

Since the conception of this product,  the agency reported 15 deaths among individuals taking Yasmin and 8 deaths with Yaz. Subsequently, doctors and pharmacists stipulate that most of these women died suddenly after developing hazardous blood clots to the brain and lungs, a well- known speculation of this product.

"One of the women, 18-year-old Miranda Scott, was working out on an elliptical machine at the Okanagan gym at the University of British Columbia when she collapsed and died three years ago, said her mother, Chip McClaughly, who is involved in a class-action lawsuit against Bayer, the maker of the birth-control pills."

In 2010, Miranda Scott, a once a perfectly healthy and active individual brutally fell to the ground  without apparent explanation. Further research was performed, only to diagnose her death to be related to several blood clot formation in her body, including in her lungs.

Due to the current sequence of events, many concerns appeared within the medical industry. Health Canada has been reviewing the health risks due to this product consumption, and issued a worldwide warning about the Bayer products in 2010. The study suggested the pills has superior risks  of blood clots than any other contraceptive method. Not only is there a higher risk to women's health, Yasmin and Yaz has 1.5 to 3 times higher fatal rate than any other product in the market.

Matthew Baer, lawyer at Siskims, is the representative of 13 families and hundreds of women who have previously suffered from this product. He alleges that Yaz and Yasmin has a drastic increase in the serious side effects, many of which are correlated with his clients including Miranda's case.

While 1 in 10 000 women will develop coagulation issues with other contraceptive capsules, 3 in 10 000 women will develop blood clots with Yaz or Yasmin.  In addition,  most of the deaths occurred within 2 months after taking this pill. In Miranda's case, it was just over one.

"And that was all it took, five weeks start to finish, and that was the end of a beautiful, beautiful girl," her mother said.

These combined products are distributed world-wide and are publicized to be efficient and secure merchandise. Medical experts and pharmacies have exposed this product to many individuals, many of which have become victims of these symptoms.

"I had been on a couple of different birth control pills over the years with no side effects, my doctor changed me to Yaz because it was supposed to be lower dosed and have fewer side effects than others. I was healthy and active. Within 3 months of starting them I was in the hospital with deep vein thrombosis and several pulmonary emboli. " mentionned Christine. Yet, another victim from the side effects of Yazmin.

To the eyes of Baer, many more cases are to be discovered in the near future.  The presentation of this product is only false advertisement in order to fancy your choice towards Yaz and Yasmin . While Bayer has already given more than one million dollars to discharge thousands of lawsuits against his company, Bayer stands beside his products with confidence.

Unfortunately, there is no immediate evidence to strictly relate the cause of death with the regular consumption of this product.

"Often it is not possible to determine if an adverse reaction (AR) reported to Health Canada is a result of using a specific health product,” the department said by email. “Other factors contributing to the AR could be a person’s health conditions or other health products they are using at the same time."

Whether are not the allegations demonstrate evidence of blood clots and other related medical issues, these events do not demonstrate a direct cause and effect with the product. Other health components and current lifestyle features must be taken in consideration before implanting  such allegation.

Certification of the Ontario lawsuit does not consider Bayer to be responsible of this development but allows the case to proceed in front of a judge.

Bayer is expected to appear in court September 4th 2013.